Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...

Follicular lymphoma is an indolent malignancy ... among a group of 220 patients with POD24 and retained follicular lymphoma histology. "One thing to also keep in mind is that some of these ...

Most follicular lymphoma cases exhibit classic clinicopathologic ... which correlate with the most aggressive histology. 3 Several variants of FL, along with examples of associated diagnostic ...

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts for 20% to 30% of all non-Hodgkin lymphoma cases. The indolent ...

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers—follicular lymphoma and marginal zone ...

81-year-old female with a remote history of follicular lymphoma was undergoing evaluation for possible disease recurrence when an incidental right breast mass was identified. 51-year-old female ...

I have follicular lymphoma, a form of blood cancer that is considered very treatable, but chronic and incurable. I will be monitored for recurrence for the rest of my life — and I am hardly alone.

The descriptive term AtLP may be used as an interim label when morphologic and molecular features are not sufficient to render a positive diagnosis of lymphoma. The development of AtLP may also ...

FDA Approves New Drug Combination for Mantle Cell LymphomaThe FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). If you have follicular ...

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.